Cargando…
Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models
Despite numerous therapeutic advances in the past decade, breast cancer is expected to cause over 42,000 deaths in the United States in 2019. Breast cancer had been considered an immunologically silent tumor; however recent findings suggest that immune cells play important roles in tumor growth even...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825145/ https://www.ncbi.nlm.nih.gov/pubmed/31700995 http://dx.doi.org/10.1038/s41523-019-0135-5 |